SHARE THIS VIDEO —
FDA greenlights new Alzheimer's drug amid safety concerns
NBC News Clone summarizes the latest on: Mmvo159438917834 - Breaking News | NBC News Clone. This article is rewritten and presented in a simplified tone for a better reader experience.
The FDA is greenlighting the drug Leqembi after it appeared to slow cognitive decline in some early stage Alzheimer’s patients in spite of some potential risks. NBC News’ Kristen Dahlgren has more details about findings from a clinical trial.
Want more summaries like this? Follow NBC News Clone for expertly filtered news from trusted sources.
